226 related articles for article (PubMed ID: 28378636)
1. Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.
Hu AX; Huang ZY; Zhang L; Shen J
Tumour Biol; 2017 Apr; 39(4):1010428317694563. PubMed ID: 28378636
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma.
Zhong Y; Liu Z; Li D; Liao Q; Li J
Biomed Res Int; 2020; 2020():3813546. PubMed ID: 33204693
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
Sedlarikova L; Gromesova B; Kubaczkova V; Radova L; Filipova J; Jarkovsky J; Brozova L; Velichova R; Almasi M; Penka M; Bezdekova R; Stork M; Adam Z; Pour L; Krejci M; Kuglík P; Hajek R; Sevcikova S
Eur J Haematol; 2017 Sep; 99(3):223-233. PubMed ID: 28543758
[TBL] [Abstract][Full Text] [Related]
5. Identification of pathway-based prognostic gene signatures in patients with multiple myeloma.
Zamani-Ahmadmahmudi M; Dabiri S; Nadimi N
Transl Res; 2017 Jul; 185():47-57. PubMed ID: 28549851
[TBL] [Abstract][Full Text] [Related]
6. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
7. One-lincRNA and five-mRNA based signature for prognosis of multiple myeloma patients undergoing proteasome inhibitors therapy.
Liu Y; Yang N; Peng X; Liu G; Zhong H; Liu L
Biomed Pharmacother; 2019 Oct; 118():109254. PubMed ID: 31357080
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma.
Li W; Yuan P; Liu W; Xiao L; Xu C; Mo Q; Xu S; He Y; Jiang D; Wang X
Front Immunol; 2022; 13():843369. PubMed ID: 35958555
[TBL] [Abstract][Full Text] [Related]
9. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
10. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
11. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
12. Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma.
Samur MK; Minvielle S; Gulla A; Fulciniti M; Cleynen A; Aktas Samur A; Szalat R; Shammas M; Magrangeas F; Tai YT; Auclair D; Keats J; Richardson P; Attal M; Moreau P; Anderson KC; Parmigiani G; Avet-Loiseau H; Munshi NC
Leukemia; 2018 Dec; 32(12):2626-2635. PubMed ID: 29749396
[TBL] [Abstract][Full Text] [Related]
13. Development of an RNA sequencing-based prognostic gene signature in multiple myeloma.
Zamani-Ahmadmahmudi M; Nassiri SM; Soltaninezhad F
Br J Haematol; 2021 Jan; 192(2):310-321. PubMed ID: 32410217
[TBL] [Abstract][Full Text] [Related]
14. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma.
Taiana E; Ronchetti D; Favasuli V; Todoerti K; Manzoni M; Amodio N; Tassone P; Agnelli L; Neri A
Haematologica; 2019 Feb; 104(2):e72-e76. PubMed ID: 30213829
[No Abstract] [Full Text] [Related]
16. High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma.
Huang LJ; Shen Y; Bai J; Wang FX; Feng YD; Chen HL; Peng Y; Zhang R; Li FM; Zhang PH; Lei XR; Xue F; Ma YP; Hu JS; He AL
Acta Haematol; 2020; 143(3):279-288. PubMed ID: 31597158
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
Decaux O; Lodé L; Magrangeas F; Charbonnel C; Gouraud W; Jézéquel P; Attal M; Harousseau JL; Moreau P; Bataille R; Campion L; Avet-Loiseau H; Minvielle S;
J Clin Oncol; 2008 Oct; 26(29):4798-805. PubMed ID: 18591550
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.
Amodio N; Di Martino MT; Neri A; Tagliaferri P; Tassone P
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S125-37. PubMed ID: 23692413
[TBL] [Abstract][Full Text] [Related]
20. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
